Answer
Yes, breastfeeding is contraindicated during ambrisentan treatment; whether ambrisentan is excreted in human breast milk is unknown, and its excretion in animal milk has not been studied.
Sources for this answer
- Volibris 5 mg film coated tabletsGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 28Document updated
Sources checked